9/19/2024: 

In response to the ongoing global challenge posed by highly pathogenic avian influenza (HPAI), we are pleased to introduce our latest veterinary diagnostic products with the most up-to-date antigens for H5N1 and H5N8 strains. These antigens are inactivated and specifically designed for use in the Haemagglutination Inhibition (HI) test to ensure accurate detection of antibodies in poultry.

H5N8 remains highly contagious and fatal to birds, with a potential, although currently limited, risk to humans. However, the H5N1 strain poses a greater threat to human health. Standard protocols require annual veterinary testing of all poultry farms for antibodies to avian influenza. Our newly developed H5N1 and H5N8 antigens are essential tools for accurate monitoring and rapid response to potential outbreaks, ensuring the health and safety of both poultry and humans.

Our new poultry diagnostic products are:

• VLDIA353 - Inactivated H5N1 antigen
  Influenza virus A/Fox/Netherlands/EMC-1/2022, HPAI H5N1, HA clade 2.3.4.4b
• VLDIA354 - Inactivated H5N8 antigen
  Influenza virus A/Chicken/Netherlands/EMC-3/2014, HPAI H5N8, HA clade 2.3.4.4b

In addition, we also have a negative chicken serum (VLDIA030) for your veterinary testing needs. These veterinary diagnostics are available now.

Order here